Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 18, 2026, titled “Glenmark Pharmaceuticals Inc., USA Launches Vancomycin Hydrochloride for Injection USP, 500mg/vial and 1 g/vial”. |SUBJECT: Press Release